Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umut Yildiz

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Redox Biology|March 23, 2023
Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugsJana Samarin, Piotr Fabrowski, Roman Kurilov, et al.
Science Advances|July 3, 2021
Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screensRui Lopes, Kathleen Sprouffske, Caibin Sheng, et al.
EMBO Molecular Medicine|July 12, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastomaHamed Alborzinia, Zhiyi Chen, Umut Yildiz, et al.
Nature Cancer|April 28, 2022
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Andrés F Flórez, Sina Kreth, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistanceZhiyi Chen, Alex Inague, Kamini Kaushal, et al.
Nature Cancer|January 3, 2025
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1-HER3 signalingRoberto Würth, Elisa Donato, Laura L Michel, et al.
Molecular Cell|November 15, 2024
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistanceZhiyi Chen, Alex Inague, Kamini Kaushal, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Redox Biology|March 23, 2023
Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugsJana Samarin, Piotr Fabrowski, Roman Kurilov, et al.
Science Advances|July 3, 2021
Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screensRui Lopes, Kathleen Sprouffske, Caibin Sheng, et al.
EMBO Molecular Medicine|July 12, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastomaHamed Alborzinia, Zhiyi Chen, Umut Yildiz, et al.
Nature Cancer|April 28, 2022
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Andrés F Flórez, Sina Kreth, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistanceZhiyi Chen, Alex Inague, Kamini Kaushal, et al.
Nature Cancer|January 3, 2025
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1-HER3 signalingRoberto Würth, Elisa Donato, Laura L Michel, et al.
Molecular Cell|November 15, 2024
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistanceZhiyi Chen, Alex Inague, Kamini Kaushal, et al.
Pageof 2